Efficacy and tolerability of bacillus Calmette-Gu érin strain Russia for the treatment of non-muscle-invasive bladder cancer: Analysis of a prospective registry
CONCLUSIONS: BCG Russia was well-tolerated and resulted in comparable RFS and PFS to historical results of prospective clinical trials with other BCG strains. The use of BCG Russia for adjuvant treatment of papillary NMIBC and therapy of carcinoma in situ of the urinary bladder could help alleviate the BCG shortage.PMID:38466867 | DOI:10.5489/cuaj.8552
Source: Canadian Urological Association Journal - Category: Urology & Nephrology Authors: Sarah Flury-Sutter Frederick Heuzeroth Emilio Arbelaez Lukas Bubendorf Heike P üschel Stefanie Hayoz Cyrill A Rentsch Source Type: research